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With the advent of high-throughput technologies, the field of systems biology has
amassed an abundance of “omics” data, quantifying thousands of cellular components
across a variety of scales, ranging from mRNA transcript levels to metabolite quantities.
Methods are needed to not only integrate this omics data but to also use this data
to heighten the predictive capabilities of computational models. Several recent studies
have successfully demonstrated how flux balance analysis (FBA), a constraint-based
modeling approach, can be used to integrate transcriptomic data into genome-scale
metabolic network reconstructions to generate predictive computational models. In this
review, we summarize such FBA-based methods for integrating expression data into
genome-scale metabolic network reconstructions, highlighting their advantages as well
as their limitations.
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INTRODUCTION
A central challenge in the development of systems biology is
the integration of high-throughput data to generate predic-
tive computational models. With the advent of high-throughput
technologies, “omics” data types have provided quantitative data
for thousands of cellular components across a variety of scales.
Genomics provides data on a cell’s DNA sequence, transcrip-
tomics on the mRNA expression of cells, proteomics on a cell’s
protein composition, and metabolomics on a cell’s metabo-
lite abundance. Computational methods are needed to reduce
this dimensionality across the wide spectrum of omics data to
improve understanding of the underlying biological processes
(Cakir et al., 2006; Pfau et al., 2011).
Metabolic network reconstructions are an advantageous plat-
form for the integration of omics data (Palsson, 2002). Assembled
in part from annotated genomes as well as biochemical, genetic,
and cell phenotype data, a metabolic network reconstruction is
a manually-curated, computational framework that enables the
description of gene-protein-reaction relationships (Chavali et al.,
2012). Numerous studies have demonstrated how such recon-
structions of metabolism can guide the development of biological
hypotheses and discoveries (Oberhardt et al., 2010; Sigurdsson
et al., 2010; Chang et al., 2011).
Flux balance analysis (FBA), a constraint-based modeling
approach, can be used to probe these network reconstructions
by predicting physiologically relevant growth rates as a function
of the underlying biochemical networks (Gianchandani et al.,
2009). To do so, FBA involves delineating constraints on the net-
work according to physicochemical, environmental, regulatory,
and thermodynamic principles (Kauffman et al., 2003; Price et al.,
2003). After applying constraints, the solution space of possible
phenotypes narrows, allowing for more accurate characterization
of the reconstructed metabolic network. Omics data can be used
to further constrain the possible solution space and enhance the
model’s predictive powers (Palsson, 2002; Lewis et al., 2012).
Given the wealth of transcriptomic data, efforts to integrate
mRNA expression data with metabolic network reconstructions,
have, in particular, made significant progress when using FBA
as an analytical platform (Covert and Palsson, 2002; Akesson
et al., 2004; Covert et al., 2004). However, despite this abun-
dance of data, the integration of expression data faces unique
challenges such as experimental and inherent biological noise,
variation among experimental platforms, detection bias, and
the unclear relationship between gene expression and reac-
tion flux (Zhang et al., 2010). Nevertheless, the past few years
have witnessed several advances in the integration of transcrip-
tomic data with genome-scale metabolic network reconstruc-
tions. Specifically, numerous FBA-driven algorithms have been
introduced that use experimentally derived mRNA transcript lev-
els to modify the network’s reactions either by inactivating them
entirely or by constraining their activity levels. Such algorithms
have demonstrated their applicability by, for example, classify-
ing tissue-specific metabolic activity in the human network and
by identifying novel drug targets in Mycobacterium tuberculosis
(Shlomi et al., 2008; Colijn et al., 2009).
In this review, we will first give an overview of the formu-
lation of FBA. Subsequently, we will summarize various FBA-
driven methods for integrating expression data into genome-scale
metabolic network reconstructions. Finally, we will survey the
limitations of these algorithms as well as look to the future
of multi-omics data integration using genome-scale metabolic
network reconstructions as the scaffold.
FLUX BALANCE ANALYSIS
FBA is a constraint-based modeling approach that charac-
terizes and predicts aspects of an organism’s metabolism
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(Gianchandani et al., 2009; Lewis et al., 2012). To use FBA, the
user supplies a metabolic network reconstruction in the form of
a stoichiometric matrix, S, where the rows in S correspond to the
metabolites of the reconstruction and the columns in S represent
reactions in the reconstruction. For each matrix element, a sto-
ichiometric coefficient sij conveys the molecularity of a certain
metabolite in a particular reaction, with sij ≥ 1 indicating that
the metabolite is a product of the reaction, sij ≤ −1 a reactant,
and sij = 0 signifies that the metabolite is not involved.
Subsequently, a system of linear equations is established by
multiplying the S matrix by a column vector, v, which contains
the unknown fluxes through each of the reactions of the Smatrix.
Under the assumption that the system operates at steady-state,
that is to say there is no net production or consumption of mass
within the system, the product of this matrix multiplication must
equal zero, S · v = 0 (Gianchandani et al., 2009). Because the
resulting system is underdetermined (i.e., too few equations, too
many unknowns), linear programming (LP) is used to optimize
for a particular flux, Z, the objective function, subject to under-
lying constraints. The objective function typically takes on the
form of:
Z = c · v
where c is a row vector of weights for each of the fluxes in col-
umn vector v, indicating howmuch each reaction in v contributes
to the objective function, Z (Lee et al., 2006; Orth et al., 2010).
Examples of objective functions include maximizing biomass,
ATP production, and the production of a metabolite of interest
(Lewis et al., 2012). The following linear program is an example
of how FBA problems are formulated:
maximize Z = c · v (1)
subject to
S · v = 0 (2)
lb ≤ v ≤ ub (3)
where (1) outlines the objective function to be optimized, (2) the
steady state assumption, and (3) describes the upper and lower
bounds, ub and lb, of each of the fluxes in v according to such
constraints as enzyme capacities, maximum uptake and secretion
rates, and thermodynamic constraints (Price et al., 2003; Jensen
and Papin, 2011). Through this application of constraints, the
solution space of physiologically feasible flux distributions for v
shrinks. Thus, the task of FBA is to find a solution to v that
lies within the bounded solution space and that optimizes the
objective function at the same time.
ALGORITHMS FOR THE INTEGRATION OF EXPRESSION
DATA
Several recently developed algorithms have demonstrated how
expression data can be incorporated into FBA models to further
constrain the flux distribution solution space in genome-scale
metabolic network reconstructions (Figure 1; Table 1). The fol-
lowing section highlights the theory behind several of these
methods as well as key differences in their structure.
GIMME
One such method that guarantees to both produce a functioning
metabolic model based on gene expression levels and quan-
tify the agreement between the model and the data is called
the Gene Inactivity Moderated by Metabolism and Expression
(GIMME) algorithm (Becker and Palsson, 2008). To execute this
algorithm, the user supplies a set of gene expression data, a
genome-scale metabolic network reconstruction, and at least one
specified metabolic functionality, or objective function, that the
cell is assumed to achieve. Broken into two steps, the GIMME
algorithm first runs FBA on the original reconstruction to find
the maximum possible flux through the specified functionali-
ties. Subsequently, under the assumption that gene expression
data correlate with reaction fluxes, GIMME compares the exper-
imental mRNA transcript levels to a user-specified threshold and
methodically removes reactions from the model whose mRNA
transcript levels fall below the given threshold. However, in the
event that the resulting model is unable to achieve the desired
objective function, GIMME solves an LP problem that adds sets
of the inactive reactions back into the system in such a way that
minimizes deviation from the expression data. To quantify this
deviation, an inconsistency score is calculated for each reaction
by multiplying the flux necessary to achieve a defined value of
the objective function and the distance between the experimen-
tal mRNA transcript level and the threshold level. By minimizing
this inconsistency score, GIMME uses expression data to define a
functioning metabolic model that meets the assumed function-
ality and is consistent with the experimentally measured gene
expression data.
iMAT
Similar to GIMME, the Integrative Metabolic Analysis Tool
(iMAT) results in a functioning model in which the fluxes of
reactions correlated with high mRNA levels are maximized and
the fluxes of reactions associated with low mRNA levels are
minimized (Shlomi et al., 2008; Zur et al., 2010). A key dif-
ference is that iMAT does not require a priori knowledge of a
defined metabolic functionality. Briefly, this method establishes
a tri-valued gene-to-reaction mapping for each reaction in the
model according to the level of gene expression in the data. More
specifically, highly, moderately, and lowly expressed genes rel-
ative to a user-specified threshold are assigned values of 1, 0,
and −1, respectively, resulting in sets of highly expressed reac-
tions (RH) and sets of lowly expressed reactions (RL). The algo-
rithm then solves a mixed integer linear programming (MILP)
problem according to stoichiometric and thermodynamic con-
straints while also maximizing RH and minimizing RL. Mirroring
GIMME, the presence of reactions is allowed to deviate from
the expression data in order for the algorithm to result in a
functioning model. Thus, like GIMME, iMAT returns a func-
tioning metabolic model that integrates expression data with a
genome-scale metabolic network reconstruction by maximizing
the number of highly expressed reactions and minimizing the
number of lowly expressed reactions; however, unlike GIMME,
this method does not demand that the user supply functionali-
ties that the model is assumed to meet. Instead, iMAT requires
that reactions catalyzed by the products of highly expressed genes
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FIGURE 1 | (A) Toy network and sample expression data for three different
experimental conditions. Panels (B), (C), (D), (E) and (F) demonstrate how
the discussed algorithms use the sample expression data to modify
the flow of reaction flux, shown in the boldness of the reaction arrow,
through the toy network. (B) GIMME compares the expression data to a
threshold and subsequently removes reactions whose expression
(Continued)
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FIGURE 1 | Continued
levels fall below the threshold. In the second case where the threshold is
0.50, the removal of R3 causes the network to not achieve its user-specified
objective function, resulting in a non-functional model; thus, it is added back
into the network to create a functional model. (C) iMAT discretizes the
expression data into lowly, moderately, and highly expressed reaction sets
and removes reactions that are lowly expressed from the network. Because
the network is not required to achieve a specified objective function, both
cases of thresholding result in a functional model. However, in the second
case where the low cutoff is 0.50 and the high cutoff is 0.75, R3 is
considered to be post-transcriptionally down-regulated because, even
though expression data shows it to be highly expressed, the resulting toy
network indicates that R3 has little, if any, reaction flux. (D) MADE
determines a sequence of binary expression states by maximizing the
statistically significant changes across the expression states and
simultaneously solves the flux balance analysis problem for each of the
experimental conditions, resulting in unique toy networks for each condition.
(E) E-Flux uses the expression data to modify the maximum possible flux,
MaxFluxi, through the relevant reactions. (F) PROM first binarizes the data
according to a threshold to determine on/off states and then determines the
probability that a gene is on when its transcription factor is also on. In this
example, we assume that the transcription factors are on for all of the genes.
Using this probability, PROM modifies the MaxFluxi through the relevant
reactions.
Table 1 | Summary of the algorithms for the integration of expression data.
Method Description Advantages Disadvantages Reference
GIMME Compares expression levels to a threshold to
determine sets of active reactions and sets of
inactive reactions in a reconstruction and returns a
functioning model that meets an assumed
objective function
Only requires one gene
expression data set
Requires thresholding of
mRNA transcript levels
relative to a user-specified
value
Becker and
Palsson, 2008
iMAT Uses expression data to determine highly active,
moderately active, and lowly active sets of
reactions in the reconstruction and solves a MILP
problem to return a functioning model
Does not require a priori
knowledge of metabolic
functionalities
Requires discretization of
expression data into lowly,
moderately and highly
expressed genes
Shlomi et al.,
2008
MADE Requires two or more sets of microarray data to
create a sequence of binary expression states for
a reconstruction’s reactions, removing the need
for arbitrary thresholding
Does not require a
user-supplied threshold to
determine which reactions
are highly expressed and
which are lowly expressed
Requires multiple datasets
for differential expression
Jensen and Papin,
2011
E-Flux Compares expression levels to a threshold and
subsequently constrains the upper bounds of the
reactions that are lowly expressed
Does not reduce gene
expression data to binary
on-off states
Requires a function to
convert expression levels
into an upper bound on
fluxes
Colijn et al., 2009
PROM Determines the probability that a gene is active
relative to the activity of its transcription factor
according to expression data and subsequently
constrains the maximum flux for relevant
reactions by a factor of this probability
Incorporates regulatory
interactions without a
mechanistic model
Requires a large dataset for
calculating transcription
factor and target gene
interactions
Chandrasekaran
and Price, 2010
are able to carry a minimum flux. By removing this need for
user-specified objective functions, iMAT bypasses assumptions
about metabolic functionalities of a particular network, which
proves advantageous for models where there is no clear objective
function, as in models of mammalian cells.
MADE
While both GIMME and iMAT rely on user-specified thresh-
old values to determine which reactions are highly expressed
and which reactions are lowly expressed, Metabolic Adjustment
by Differential Expression (MADE) uses statistically significant
changes in gene expression measurements to determine sequences
of highly and lowly expressed reactions (Jensen and Papin, 2011).
In order for MADE to generate these expression states, the user
must supply expression data from two or more experimental con-
ditions. For each gene, the algorithm calculates the changes in
the mean expression level across the conditions and returns a
sequence of differences, according to an increase (+1), decrease
(−1) or no change (0) in mRNA levels. MADE then deter-
mines each gene’s sequence of binary expression states across the
experimental conditions by finding the pattern of changes that
most closely mirrors the sequence of differences. While determin-
ing this sequence of binary states, MADE simultaneously solves
the FBA problem for each condition, resulting in a sequence of
functioning models. The statistical significance of the expres-
sion changes is used as a weighting to resolve conflicts between
expression changes and model functionality. MADE’s reliance
on statistically significant changes across various experimental
conditions to constrain reaction activity avoids the arbitrariness
surrounding the determination of a proper threshold in prior
methods. As will be discussed in more detail later, the lack of
correlation between mRNA levels and protein levels makes it dif-
ficult to accurately determine when genes are “turned on,” and
when they are “turned off.” Therefore, in eliminating this need
for thresholding, MADE removes significant user-bias from the
system.
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E-FLUX
Whereas GIMME, iMAT, andMADE incorporate gene expression
data into theirmodels by reducing gene expression levels to binary
states, the method E-Flux attempts to more directly incorporate
gene expression data into FBA optimization problems by con-
straining themaximumpossible flux through the reactions (Colijn
et al., 2009). Rather than setting the upper bounds of a reaction
to some large constant or 0, mirroring the implementation of
binary-based algorithms, E-Flux constrains the upper bound of a
reaction according to its respective gene expression level relative
to a particular threshold. In cases where the gene expression data
is below a certain threshold, tight constraints are placed on the
flux through the corresponding reactions in the reconstruction;
conversely, in cases where the gene expression is above a certain
threshold, loose constraints are placed on the flux through the
corresponding reactions. The width of this “flux cone” is adjusted
by changing the maximum possible flux in the upper bound of
the FBA optimization problem according to some function of
the gene expression level. While the other algorithms described
above use mRNA expression data to predict binary states for the
network reactions, E-Flux uses the transcript levels to determine
the degree to which a reaction is active or inactive. In doing so,
E-Flux offers a more physiologically relevant depiction of the
continuous nature of the reaction activity gradient.
PROM
In contrast to the other methods discussed, which focused solely
on integrating gene expression data into genome-scale metabolic
network reconstructions, Probabilistic Regulation of Metabolism
(PROM) aims to fuse together metabolic networks and transcrip-
tion regulatory networks with expression data (Chandrasekaran
and Price, 2010). To run PROM, the user supplies a genome-scale
metabolic network reconstruction, a regulatory network struc-
ture describing transcription factors and their targets, and a range
of expression data from various environmental and genetic per-
turbations. Given this expression data, PROM binarizes the genes
with respect to a user-supplied threshold to evaluate the likeli-
hood of the expression of a target gene given the expression of
that gene’s transcription factor. For example, a probability of 0.6
for gene X when its transcription factor Y is on represents that
in 60% of the microarray samples when transcription factor Y
is highly expressed, gene X exhibits high expression. Upon cal-
culating these probabilities, PROM then incorporates them into
FBA by constraining the upper bound to P × Vmax, where P is
the probability that the gene is on for that reaction and Vmax
is the maximum flux through that reaction. Therefore, although
PROMdoes binarize the data to calculate the probabilities of gene
activity, the actual integration of the expression data into the FBA
model does not reduce the reactions to on/off states; rather, sim-
ilarly to E-Flux, PROM constrains the maximum flux through
relevant reactions according to transcription factor activity.
CHALLENGES FACING THE INTEGRATION OF
EXPRESSION DATA
Each of the methods discussed hinges on the assumption that
mRNA transcript levels are a strong indicator for the level
of protein activity. For instance, GIMME and iMAT assume
that mRNA levels below a certain threshold suggest that the
corresponding reactions are inactive. MADE follows a similar
logic, turning reactions on and off depending on the changes in
mRNA transcript levels. E-Flux and PROMassume that transcript
levels indicate the degree to which reactions are active, evident in
the constraining of the upper bounds in the FBA optimization
problems associated with these methods.
However, recent studies have called into question the valid-
ity of this assumption which correlates mRNA transcript levels
to protein levels. In one of the first large-scale screens to assess the
correlation between mRNA and protein expression, the Pearson
product moment correlation coefficient, a measure of the lin-
ear dependence between two variables ranging from −1 to 1,
was calculated to be 0.356 for yeast data (Gygi et al., 1999).
Subsequently, several groups have also tried to assess this rela-
tionship between mRNA and protein levels by calculating the
Spearman rank correlation, an analogue of the Pearson product
moment correlation coefficient using ranked variables. With val-
ues ranging from 0.21 to 0.61, this positive correlation between
mRNA abundance and protein abundance is moderate at best
(Ideker et al., 2001; Griffin et al., 2002; Washburn et al., 2003;
Moxley et al., 2009). Possible reasons for this discrepancy include
post-translational modifications, post-transcriptional regulation
and enzyme kinetics (Zhang et al., 2010). Interestingly, a recent
study demonstrated that the level of transcriptional regulatory
activity on observed protein expression varies from pathway to
pathway according to an evolutionary trade-off between minimiz-
ing protein cost and rapidly responding to environmental changes
(Wessely et al., 2011).
Acknowledging this questionable association between tran-
scriptomic and proteomic data, the discussed methods claim to
treat the assumption that mRNA levels serve as a strong indicator
for protein activity as a “soft constraint.” Rather than requiring
that the reconstruction mirror the expression data exactly, the
methods allow for deviations in the FBA flux solution space in
order to generate a functioning model that adheres to the speci-
fied constraints. In the case of GIMME, highly expressed reactions
are prioritized relative to lowly expressed reactions; however, in
the event that an optimal, functioning solution cannot be found,
the assumption can be violated and lowly expressed reactions can
be added back into the reconstruction. Thus, this assumption that
mRNA transcript levels correlate to protein levels serves as a cue
rather than a mandate.
CONCLUSION
The above methods have been used to not only integrate expres-
sion data from a variety of sources but to also make progress
toward overcoming key challenges in the field of systems biology.
For instance, iMAT, highlighting its applicability in multi-cellular
organisms, was used to curate the human metabolic network
reconstruction and predict tissue-specific gene activity levels in
ten human tissues (Duarte et al., 2007; Shlomi et al., 2008).
Additionally, both E-Flux and PROM have been used to discover
novel drug targets in Mycobacterium tuberculosis (Colijn et al.,
2009; Chandrasekaran and Price, 2010).
Given the recent success with using genome-scale metabolic
network reconstructions as a platform for integrating expres-
sion data, efforts should focus on multi-omics data integration.
A handful of methods have already been introduced that integrate
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two or more types of omics data into genome-scale metabolic
network reconstructions. For example, despite the current dearth
of quantitative metabolomics data, a method has been devel-
oped that demonstrates how semi-quantitative metabolomics
data can be used with transcriptomic data to curate genome-
scale metabolic network reconstructions and identify key reac-
tions involved in the production of certain metabolites (Cakir
et al., 2006). Another algorithm, called Integrative Omics-
Metabolic Analysis (IOMA), integrates metabolomics data and
proteomics data into a genome-scale metabolic network recon-
struction by evaluating kinetic rate equations subject to quantita-
tive omicsmeasurements (Yizhak et al., 2010). Furthermore, Mass
Action Stoichiometric Simulation (MASS) uses metabolomic,
fluxomic, and proteomic data to transform a static stoichiometric
reconstruction of an organism into a large-scale dynamic network
model (Jamshidi and Palsson, 2010). And finally, building off of
iMAT, the Model-Building Algorithm (MBA) utilizes literature-
based knowledge, transcriptomic, proteomic, metabolomic, and
phenotypic data to curate the human metabolic network recon-
struction to derive a more complete picture of tissue-specific
metabolism (Jerby et al., 2010). Such algorithms show promise
in their ability to easily integrate high-throughput data into
genome-scale metabolic network reconstructions to generate
phenotypically accurate and predictive computational models.
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